Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)
₹926.90
Mkt cap
₹8,931 Cr
P/E ratio
49.30
P/B
5.01
Div yield
0.05%
ROE
10.20%
ROCE
12.90%
EPS (TTM)
₹18.80
Book value
₹185
52W range
538–1,184
Sector
Healthcare
Price history
Previous close
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh. [1]
NSE YATHARTHBSE 543950
Health check
Constructive
ValuationFair
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−21.71% from high₹927
₹538+72.21% from low₹1,184
Current
₹926.90
Prev close
₹923.30
Day
+0.39%
Price performance
1D
+0.48%
1W
−0.44%
1M
−16.27%
3M
+12.31%
6M
+15.54%
1Y
+15.08%
YTD
+32.52%
Financials
Revenue, profit & margin
P/E ratio
49.3×
YATHARTH is 11% above the sector median of 44.4×
YATHARTH49.3×
Sector median44.4×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 155 | 171 | 167 | 178 | 212 | 218 | 219 | 232 | 258 | 279 | 320 | 342 | 393 | |
| Expenses | 113 | 126 | 120 | 131 | 158 | 163 | 164 | 175 | 193 | 215 | 246 | 262 | 301 | |
| Operating Profit | 41 | 46 | 46 | 47 | 54 | 55 | 55 | 57 | 64 | 65 | 74 | 80 | 92 | |
| OPM % | 27% | 27% | 28% | 26% | 25% | 25% | 25% | 25% | 25% | 23% | 23% | 23% | 23% | |
| Other Income | 1 | 4 | 5 | 6 | 4 | 3 | 4 | 5 | 9 | 9 | 8 | 7 | 4 | |
| Interest | 6 | 3 | 0 | 0 | 3 | 2 | 2 | 1 | 0 | 0 | 1 | 5 | 7 | |
| Depreciation | 7 | 7 | 8 | 8 | 11 | 16 | 17 | 13 | 15 | 19 | 24 | 30 | 28 | |
| Profit before tax | 29 | 40 | 44 | 44 | 43 | 40 | 40 | 49 | 59 | 55 | 57 | 52 | 61 | |
| Tax % | 35% | 30% | 33% | 13% | 29% | 23% | 24% | 20% | 28% | 25% | 25% | 14% | 26% | |
| Net Profit | 19 | 28 | 29 | 38 | 30 | 31 | 30 | 39 | 42 | 41 | 43 | 45 | 45 | |
| EPS in Rs | 2.91 | 3.21 | 3.44 | 4.47 | 3.54 | 3.61 | 3.16 | 4.02 | 4.36 | 4.28 | 4.71 | 4.93 | 4.88 | |
| Raw PDF |
Earnings
Results dates & reactionsNext results
3 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −3.68% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 10 Aug '26◦ |
| Earnings day | −3.68% |
| +1 day | −3.33% |
| +5 days | −4.98% |
| +15 days | +8.46% |
| +30 days | +29.31% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Sep 202655.80%Promoter
Promoters55.80%
FIIs7.05%1.43
DIIs10.94%0.10
Public26.21%1.53
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Yatharth Hospit. | ₹926.90 | 49.30 | 8,931 | 0.05% | 45 | +11.94% | 393 | +52.33% | 12.90% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Concall transcripts35
TranscriptAug 2026PPTAug 2026RECAug 2026PPTAug 2026TranscriptJun 2026PPTJun 2026RECJun 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025RECAug 2025TranscriptJun 2025PPTJun 2025TranscriptFeb 2025PPTFeb 2025RECFeb 2025TranscriptNov 2024PPTNov 2024PPTNov 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 29 Oct - We hereby submit Schedule of Earnings Conference Call Q2FY27.Board Meeting Intimation for Unaudited Financial Results For Q2FY27 26 Oct - Board meeting on November 3, 2026 to approve Q2 and half-year unaudited financial results.Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 16 Oct - EGM on Oct 15 approved capital increase, preferential issue of equity shares/warrants, and AOA amendments.Voting Results Of The 1St/2026-27 Extra-Ordinary General Meeting 16 Oct - EGM approved authorised capital increase, preferential issue, amended AOA, rights, and upside share arrangement.Shareholder Meeting / Postal Ballot-Outcome of EGM 15 Oct